Research
Synergy MD Specialist Group actively participates in clinical trials, which provide invaluable benefits to both patients and doctors.
Our clinical trials offer access to cutting-edge treatments for people in our community.
What are clinical trials?
Available at select sites in Canada, and globally, clinical trials provide access to medications and health care that is not readily available to patients and may not become available for years to come.
Synergy MD Specialist Group works with major leading pharmaceutical companies to offer clinical trials for both asthma and chronic obstructive pulmonary disease (COPD), consisting of biologics (injections/IV treatment) and inhaled medications.
If you have a respiratory condition and are interested in participating in one of our clinical trials listed below, please contact our study team to see if it might be right for you. Our clinical research site is a member of Network of Networks (N2 Canada).
Currently enrolling COPD trials
Sponsor
Sanofi-Aventis Canada Inc.
Protocol Short Title: BOREAS
Protocol Title: A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) with Type 2 inflammation. (EFC15804)
Additional Information: https://clinicaltrials.gov/show/
Currently Enrolling Asthma Trials
Sponsor
AstraZeneca
Protocol Short Title: Navigator
Protocol Title: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma.
Additional Information: http://www.clinicaltrials.gov/show/NCT03347279
Sponsor
GlaxoSmithKline
Protocol Short Title: 207597
Protocol Title: A randomized, double-blind, parallel group, multicenter, stratified study evaluating the efficacy and safety of repeat doses of GSK3772847 compared with placebo in participants with moderately severe asthma.
Additional Information: https://clinicaltrials.gov/ct2/show/NCT03207243
Sponsor
AstraZeneca
Protocol Short Title: POWER
Protocol Title: Patient Outcomes Real World Evidence Registry (POWER). A Non-Interventional Post-Authorization Primary Data Collection Study of FASENRA® (benralizumab) in Adult Patients with Severe, Eosinophilic Asthma.
Additional Information: https://clinicaltrials.gov/ct2/show/NCT03833141